Please try another search
Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China and internationally. The company provides product formulations, such as pills, powders, liquors, capsules, oral liquids, and dripping pills in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, tonic and soothe the nerves, digestive system, pediatrics, expelling wind and dampness, orthopedics, five senses, skin surgery, spiritual, and food alcohol diseases. It sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Piantan Fuxing pills, etc. The company was founded in 1997 and is headquartered in Beijing, China. Beijing Tongrentang Co., Ltd is a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.
Name | Age | Since | Title |
---|---|---|---|
Yi Zang | 45 | 2018 | Director |
Baigang Liu | 54 | 2018 | Director |
Jie Man | 47 | 2018 | Director |
Fuguo Mao | 45 | 2018 | Chairman of the Supervisory Board |
Chaohua Zhang | 48 | 2021 | GM & Director |
Kai Ting Wen | 45 | 2020 | Chief Accountant & Director |
Yanjiang Qiao | 67 | 2021 | Independent Director |
Shubing Di | 48 | 2021 | Chairman |
Weiping Kong | 54 | 2021 | External Supervisor |
Shuwen Pang | 36 | 2021 | Employee Representative Supervisor |
Guihua Wang | 62 | 2021 | Independent Director |
Tianliang Liu | 60 | 2021 | Employee Representative Supervisor |
Zhao Wang | 61 | 2021 | Independent Director |
Jixiong Wang | 38 | 2020 | Supervisor |
Li Yang | 45 | 2021 | Deputy GM & Director |
Xingyu Wu | 47 | - | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review